• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Arcellx, Inc. - Common Stock (NQ: ACLX )

    52.18 +2.16 (+4.32%)
    Streaming Delayed Price Updated: 4:00 PM EDT, May 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 542,055
    Open 50.27
    Bid (Size) 48.59 (1)
    Ask (Size) 65.24 (1)
    Prev. Close 50.02
    Today's Range 50.19 - 53.97
    52wk Range 30.74 - 75.10
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Peering Into Arcellx's Recent Short Interest
    Via Benzinga
    Arcellx to Participate in the 23rd Annual Needham Virtual Healthcare Conference
    From Arcellx, Inc.
    Via Business Wire

    Performance

    YTD
    -7.07%
    -7.07%
    1 Month
    -22.10%
    -22.10%
    3 Month
    -15.62%
    -15.62%
    6 Month
    +51.73%
    +51.73%
    1 Year
    +24.50%
    +24.50%

    More News

    Read More
    Arcellx to Participate at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
    From Arcellx, Inc.
    Via Business Wire
    Arcellx's Lead Asset Can Potentially Outperform Bristol-Myers Squibb, Johnson & Johnson's Multiple Myeloma Cell Therapies: Morgan Stanley
    Via Benzinga
    Arcellx Analysts Boost Their Forecasts After Q4 Results
    Via Benzinga
    Needham Maintains Buy Rating for Arcellx: Here's What You Need To Know
    Via Benzinga
    Where Arcellx Stands With Analysts
    Via Benzinga
    The 3 Biotech Stocks That Could Make Your February Unforgettable
    Via InvestorPlace
    Decoding Bearish Analog And The Warning Signs You Can't Ignore
    Via Talk Markets
    Topics Stocks
    Exposures US Equities
    Healthcare Heroes: 3 Biotech Stocks Poised to Cure What Ails the Market
    Via InvestorPlace
    Exposures Product Safety
    Blood Cancer Player Arcellx Finds Place On Analyst Conviction List - Potential Room For Growth In 2024
    Via Benzinga
    Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development
    Via InvestorPlace
    Why Johnson Controls International Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Blood Cancer Player Arcellx's Lead Product Exceeds Expectations, Analysts Say
    Via Benzinga
    Chart Of The Day: Arcellx - Reimagining Cell Therapy
    Via Talk Markets
    3 Biotech Stocks That Could Be Multibaggers in the Making
    Via InvestorPlace
    Arcellx, A Top 2% Stock, Breaks Out After Inking A $285 Million Deal With Gilead
    Via Investor's Business Daily
    Kite and Arcellx Announce Expansion in Strategic Partnership
    From Gilead Sciences, Inc.
    Via Business Wire
    Why Is Blood Cancer Focused Arcellx Stock Trading Higher Today?
    Via Benzinga
    7 Biotech Stocks to Get In Now Before Investors Catch On
    Via InvestorPlace
    Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Starbucks, Teleflex, Roku, Shopify And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Cancer Drug Approval? 3 Biotech Stocks on the Brink of Breakthroughs
    Via InvestorPlace
    Analysts Stay Bullish On Arcellx's CART-ddBCMA's Long-term Therapeutic Potential
    Via Benzinga
    Exposures Product Safety
    Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2023
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.